10-Q 1 osis-20240930x10q.htm 10-Q
http://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherAssetsNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesCurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrenthttp://fasb.org/us-gaap/2024#OtherLiabilitiesNoncurrent0001039065--06-302025Q1false0000falsefalsefalsefalsefalsefalsehttp://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrMember0001039065us-gaap:CommonStockMember2024-09-300001039065us-gaap:RetainedEarningsMember2024-09-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-09-300001039065us-gaap:RetainedEarningsMember2024-06-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-06-300001039065us-gaap:RetainedEarningsMember2023-09-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-09-300001039065us-gaap:RetainedEarningsMember2023-06-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-06-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-06-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-06-300001039065us-gaap:EmployeeStockOptionMember2024-06-300001039065osis:ShareBasedEmployeeCompensationPlansMember2024-09-300001039065us-gaap:RestrictedStockUnitsRSUMember2024-06-300001039065osis:PerformanceBasedRestrictedStockUnitsMember2024-07-012024-09-300001039065osis:PerformanceBasedRestrictedStockUnitsMember2023-07-012023-09-3000010390652024-10-012024-09-300001039065us-gaap:FacilityClosingMember2024-09-300001039065us-gaap:EmployeeSeveranceMember2024-09-300001039065us-gaap:AcquisitionRelatedCostsMember2024-09-300001039065osis:ChargesRelatedToLitigationMember2024-09-300001039065us-gaap:FacilityClosingMember2024-06-300001039065us-gaap:EmployeeSeveranceMember2024-06-300001039065us-gaap:AcquisitionRelatedCostsMember2024-06-300001039065osis:ChargesRelatedToLitigationMember2024-06-300001039065us-gaap:LeaseholdImprovementsMember2024-09-300001039065us-gaap:LandMember2024-09-300001039065us-gaap:FurnitureAndFixturesMember2024-09-300001039065us-gaap:EquipmentMember2024-09-300001039065us-gaap:ConstructionInProgressMember2024-09-300001039065us-gaap:ComputerSoftwareIntangibleAssetMember2024-09-300001039065us-gaap:ComputerEquipmentMember2024-09-300001039065us-gaap:BuildingAndBuildingImprovementsMember2024-09-300001039065osis:ComputerSoftwareImplementationInProcessMember2024-09-300001039065us-gaap:LeaseholdImprovementsMember2024-06-300001039065us-gaap:LandMember2024-06-300001039065us-gaap:FurnitureAndFixturesMember2024-06-300001039065us-gaap:EquipmentMember2024-06-300001039065us-gaap:ConstructionInProgressMember2024-06-300001039065us-gaap:ComputerSoftwareIntangibleAssetMember2024-06-300001039065us-gaap:ComputerEquipmentMember2024-06-300001039065us-gaap:BuildingAndBuildingImprovementsMember2024-06-300001039065osis:ComputerSoftwareImplementationInProcessMember2024-06-300001039065osis:ConvertibleSeniorNotesDue2029Member2024-07-192024-07-190001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2024-07-012024-09-300001039065us-gaap:AccumulatedOtherComprehensiveIncomeMember2023-07-012023-09-300001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2024-07-012024-09-300001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2024-07-012024-09-300001039065us-gaap:IntersegmentEliminationMember2024-07-012024-09-300001039065us-gaap:CorporateNonSegmentMember2024-07-012024-09-300001039065osis:HealthcareDivisionMember2024-07-012024-09-300001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2023-07-012023-09-300001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2023-07-012023-09-300001039065us-gaap:IntersegmentEliminationMember2023-07-012023-09-300001039065us-gaap:CorporateNonSegmentMember2023-07-012023-09-300001039065osis:HealthcareDivisionMember2023-07-012023-09-300001039065us-gaap:CorporateMember2023-07-012023-09-300001039065srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001039065us-gaap:RevolvingCreditFacilityMember2024-09-300001039065osis:TermLoanMember2024-09-300001039065us-gaap:LineOfCreditMember2024-09-300001039065osis:LettersOfCreditSubFacilityMember2024-09-300001039065us-gaap:TrademarksMember2024-09-300001039065us-gaap:TrademarksMember2024-06-300001039065osis:SecurityDivisionMember2024-07-012024-09-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2024-07-012024-09-300001039065osis:HealthcareDivisionMember2024-07-012024-09-300001039065osis:SecurityDivisionMember2024-09-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2024-09-300001039065osis:HealthcareDivisionMember2024-09-300001039065osis:SecurityDivisionMember2024-06-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2024-06-300001039065osis:HealthcareDivisionMember2024-06-300001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-09-300001039065us-gaap:PatentsMember2024-09-300001039065us-gaap:DevelopedTechnologyRightsMember2024-09-300001039065osis:CustomerRelationshipsOrderOrProductionBacklogMember2024-09-300001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-06-300001039065us-gaap:PatentsMember2024-06-300001039065us-gaap:DevelopedTechnologyRightsMember2024-06-300001039065osis:CustomerRelationshipsOrderOrProductionBacklogMember2024-06-300001039065us-gaap:RestrictedStockUnitsRSUMember2024-07-012024-09-300001039065us-gaap:EmployeeStockOptionMember2024-07-012024-09-300001039065us-gaap:RestrictedStockUnitsRSUMember2024-09-300001039065us-gaap:EmployeeStockOptionMember2024-09-300001039065us-gaap:ForeignExchangeForwardMember2024-09-300001039065us-gaap:ForeignExchangeForwardMember2024-06-300001039065us-gaap:InterestRateSwapMember2024-09-300001039065us-gaap:InterestRateSwapMember2024-06-300001039065osis:ConvertibleSeniorNotesDue2029Member2024-07-310001039065osis:FiveConsecutiveBusinessDaysAfterSpecifiedPeriodMember2024-07-012024-09-300001039065osis:CalenderQuarterCommencingAfterQuarterEndedOnSeptember302024Member2024-07-012024-09-300001039065osis:ConvertibleSeniorNotesDue2029Member2024-07-012024-09-300001039065srt:MinimumMemberus-gaap:RevolvingCreditFacilityMember2024-07-012024-09-300001039065srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2024-07-012024-09-300001039065us-gaap:RevolvingCreditFacilityMember2024-07-012024-09-300001039065us-gaap:ServiceMember2024-07-012024-09-300001039065us-gaap:ProductMember2024-07-012024-09-300001039065us-gaap:ServiceMember2023-07-012023-09-300001039065us-gaap:ProductMember2023-07-012023-09-300001039065us-gaap:FairValueInputsLevel2Member2024-09-300001039065osis:ConvertibleSeniorNotesDue2029Member2024-09-300001039065osis:PrivatelyHeldProviderOfRadioFrequencyTechnologyMember2024-09-300001039065osis:OneCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberosis:SecurityDivisionMember2024-07-012024-09-300001039065osis:CustomerTwoMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMemberosis:SecurityDivisionMember2024-07-012024-09-300001039065osis:NoCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2024-07-012024-09-300001039065osis:NoCustomerMemberus-gaap:AccountsReceivableMemberus-gaap:CustomerConcentrationRiskMember2023-07-012024-06-300001039065osis:OneCustomerMemberus-gaap:SalesRevenueNetMemberus-gaap:CustomerConcentrationRiskMemberosis:SecurityDivisionMember2023-07-012023-09-3000010390652023-09-3000010390652023-06-300001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2024-01-012024-09-300001039065us-gaap:SoftwareAndSoftwareDevelopmentCostsMember2023-01-012023-09-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2024-07-012024-09-300001039065osis:OptoelectronicsAndManufacturingDivisionMember2023-07-012023-09-300001039065osis:PrivatelyHeldProviderOfCriticalMilitarySpaceAndSurveillanceSolutionsMember2024-07-012024-09-300001039065us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001039065us-gaap:FairValueInputsLevel3Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001039065us-gaap:SeriesOfIndividuallyImmaterialBusinessAcquisitionsMember2024-09-300001039065osis:PrivatelyHeldProviderOfRadiationTechnologyMember2023-10-310001039065osis:PrivatelyHeldContractManufacturingBusinessMember2023-12-012023-12-310001039065osis:PrivatelyHeldProviderOfRadiationTechnologyMember2023-10-012023-10-310001039065osis:SecurityDivisionMember2024-07-012024-09-300001039065osis:OtherOperationalEfficiencyActivitiesMember2024-07-012024-09-300001039065osis:SecurityDivisionMember2023-07-012023-09-300001039065osis:OtherOperationalEfficiencyActivitiesMember2023-07-012023-09-300001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2024-09-300001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2024-09-300001039065us-gaap:IntersegmentEliminationMember2024-09-300001039065us-gaap:CorporateNonSegmentMember2024-09-300001039065osis:HealthcareDivisionMember2024-09-300001039065us-gaap:OperatingSegmentsMemberosis:SecurityDivisionMember2024-06-300001039065us-gaap:OperatingSegmentsMemberosis:OptoelectronicsAndManufacturingDivisionMember2024-06-300001039065us-gaap:IntersegmentEliminationMember2024-06-300001039065us-gaap:CorporateNonSegmentMember2024-06-300001039065osis:HealthcareDivisionMember2024-06-300001039065osis:ConvertibleSeniorNotesDue2029Member2024-07-012024-09-300001039065us-gaap:SellingGeneralAndAdministrativeExpensesMember2024-07-012024-09-300001039065us-gaap:ResearchAndDevelopmentExpenseMember2024-07-012024-09-300001039065us-gaap:CostOfSalesMember2024-07-012024-09-300001039065us-gaap:SellingGeneralAndAdministrativeExpensesMember2023-07-012023-09-300001039065us-gaap:ResearchAndDevelopmentExpenseMember2023-07-012023-09-300001039065us-gaap:CostOfSalesMember2023-07-012023-09-300001039065us-gaap:RetainedEarningsMember2024-07-012024-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2024-07-012024-09-300001039065us-gaap:RetainedEarningsMember2023-07-012023-09-300001039065us-gaap:CommonStockIncludingAdditionalPaidInCapitalMember2023-07-012023-09-300001039065srt:MinimumMemberosis:PrivatelyHeldProviderOfCriticalMilitarySpaceAndSurveillanceSolutionsMember2024-09-012024-09-300001039065srt:MaximumMemberosis:PrivatelyHeldProviderOfCriticalMilitarySpaceAndSurveillanceSolutionsMember2024-09-012024-09-300001039065us-gaap:CommonStockMember2022-09-300001039065srt:MinimumMemberosis:PerformanceBasedRestrictedStockUnitsMember2024-07-012024-09-300001039065srt:MaximumMemberosis:PerformanceBasedRestrictedStockUnitsMember2024-07-012024-09-300001039065us-gaap:RestrictedStockUnitsRSUMemberosis:ShareBasedEmployeeCompensationPlansMember2024-07-012024-09-300001039065us-gaap:FacilityClosingMember2024-07-012024-09-300001039065us-gaap:EmployeeSeveranceMember2024-07-012024-09-300001039065us-gaap:AcquisitionRelatedCostsMember2024-07-012024-09-300001039065osis:ChargesRelatedToLitigationMember2024-07-012024-09-300001039065srt:MaximumMemberus-gaap:RevolvingCreditFacilityMember2024-09-300001039065us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-09-300001039065us-gaap:FairValueMeasurementsRecurringMember2024-09-300001039065us-gaap:FairValueInputsLevel2Memberus-gaap:FairValueMeasurementsRecurringMember2024-06-300001039065us-gaap:FairValueMeasurementsRecurringMember2024-06-3000010390652023-07-012023-09-300001039065osis:ConvertibleSeniorNotesDue2029Member2024-07-012024-07-310001039065osis:ConvertibleSeniorNotesDue2029Member2024-09-3000010390652024-09-3000010390652024-06-300001039065us-gaap:AccountsReceivableMemberosis:SecurityDivisionMember2024-07-012024-09-300001039065us-gaap:SalesRevenueNetMember2024-07-012024-09-300001039065us-gaap:AccountsReceivableMember2023-07-012024-06-300001039065osis:PrivatelyHeldProviderOfCriticalMilitarySpaceAndSurveillanceSolutionsMember2024-09-300001039065osis:PrivatelyHeldProviderOfCriticalMilitarySpaceAndSurveillanceSolutionsMember2024-09-012024-09-3000010390652024-10-2100010390652024-07-012024-09-30xbrli:sharesiso4217:USDxbrli:pureosis:customeriso4217:USDxbrli:sharesosis:Dosis:segment

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2024

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from              to             

Commission File Number 000-23125

Graphic

OSI SYSTEMS, INC.

(Exact name of registrant as specified in its charter)

Delaware

    

33-0238801

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification No.)

12525 Chadron Avenue

Hawthorne, California 90250

(Address of principal executive offices) (Zip Code)

(310) 978-0516

(Registrant’s telephone number, including area code)

N/A

(Former name, former address and former fiscal year, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

    

Trading Symbol(s)

    

Name of each exchange on which registered

Common Stock, $0.001 par value

OSIS

The Nasdaq Global Select Market

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes  No 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes No 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer 

   

Accelerated filer 

Non-accelerated filer 

Smaller reporting company 

Emerging growth company 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  No 

As of October 21, 2024, there were 16,710,749 shares of the registrant’s common stock outstanding.

OSI SYSTEMS, INC.

INDEX

PAGE

PART I — FINANCIAL INFORMATION

3

Item 1 —

Financial Statements (Unaudited)

3

Condensed Consolidated Balance Sheets at June 30, 2024 and September 30, 2024

3

Condensed Consolidated Statements of Operations for the three months ended September 30, 2023 and 2024

4

Condensed Consolidated Statements of Comprehensive Income for the three months ended September 30, 2023 and 2024

5

Condensed Consolidated Statements of Stockholders’ Equity for the three months ended September 30, 2023 and 2024

6

Condensed Consolidated Statements of Cash Flows for the three months ended September 30, 2023 and 2024

7

Notes to Condensed Consolidated Financial Statements

8

Item 2 —

Management’s Discussion and Analysis of Financial Condition and Results of Operations

23

Item 3 —

Quantitative and Qualitative Disclosures about Market Risk

28

Item 4 —

Controls and Procedures

29

PART II — OTHER INFORMATION

30

Item 1 —

Legal Proceedings

30

Item 1A —

Risk Factors

30

Item 2 —

Unregistered Sales of Equity Securities and Use of Proceeds

30

Item 3 —

Defaults Upon Senior Securities

30

Item 4 —

Mine Safety Disclosures

30

Item 5 —

Other Information

30

Item 6 —

Exhibits

31

Signatures

32

2

PART I—FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)

(amounts in thousands, except share amounts and par value)

June 30, 

September 30, 

    

2024

    

2024

ASSETS

CURRENT ASSETS:

Cash and cash equivalents

$

95,353

$

85,053

Accounts receivable, net

 

648,155

687,610

Inventories

 

397,939

456,030

Prepaid expenses and other current assets

 

74,077

81,310

Total current assets

 

1,215,524

1,310,003

Property and equipment, net

 

113,967

124,613

Goodwill

 

351,480

381,444

Intangible assets, net

 

139,529

183,222

Other assets

 

115,508

114,232

Total assets

$

1,936,008

$

2,113,514

LIABILITIES AND STOCKHOLDERS’ EQUITY

CURRENT LIABILITIES:

Bank lines of credit

$

384,000

$

259,000

Current portion of long-term debt

 

8,167

8,217

Accounts payable

 

191,149

191,932

Accrued payroll and related expenses

 

46,732

41,048

Advances from customers

 

53,431

63,996

Other accrued expenses and current liabilities

 

131,158

148,343

Total current liabilities

 

814,637

712,536

Long-term debt, net

 

129,383

468,084

Other long-term liabilities

 

128,505

146,399

Total liabilities

 

1,072,525

1,327,019

Commitments and contingencies (Note 10)

STOCKHOLDERS’ EQUITY:

Preferred stock, $0.001 par value—10,000,000 shares authorized; no shares issued or outstanding

 

Common stock, $0.001 par value—100,000,000 shares authorized; issued and outstanding, 17,055,497 shares at June 30, 2024 and 16,710,749 shares at September 30, 2024

 

24,289

17

Retained earnings

 

861,230

810,553

Accumulated other comprehensive loss

 

(22,036)

(24,075)

Total stockholders’ equity

 

863,483

786,495

Total liabilities and stockholders’ equity

$

1,936,008

$

2,113,514

See accompanying notes to condensed consolidated financial statements.

3

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

(amounts in thousands, except per share data)

Three Months Ended September 30, 

    

2023

    

2024

Net revenues:

Products

$

199,709

$

255,808

Services

 

79,501

88,199

Total net revenues

 

279,210

344,007

Cost of goods sold:

Products

 

136,983

170,422

Services

 

43,482

52,083

Total cost of goods sold

 

180,465

222,505

Gross profit

 

98,745

121,502

Operating expenses:

Selling, general and administrative

 

59,798

72,223

Research and development

 

15,922

17,773

Restructuring and other charges, net

 

466

1,178

Total operating expenses

 

76,186

91,174

Income from operations

 

22,559

30,328

Interest and other expense, net

 

(5,748)

(7,359)

Income before income taxes

 

16,811

22,969

Provision for income taxes

 

(3,932)

(5,033)

Net income

$

12,879

$

17,936

Earnings per share:

Basic

$

0.77

$

1.07

Diluted

$

0.75

$

1.05

Shares used in per share calculation:

Basic

 

16,825

16,742

Diluted

 

17,175

17,055

See accompanying notes to condensed consolidated financial statements.

4

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (UNAUDITED)

(amounts in thousands)

    

Three Months Ended September 30, 

    

2023

    

2024

Net income

$

12,879

$

17,936

Other comprehensive income (loss):

Foreign currency translation adjustment, net of tax

 

(3,172)

1,181

Net unrealized gain (loss) on derivatives, net of tax

1,147

(3,220)

Other, net of tax

137

Other comprehensive loss

(1,888)

(2,039)

Comprehensive income

$

10,991

$

15,897

See accompanying notes to condensed consolidated financial statements.

5

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED)

(amounts in thousands, except share data)

Three Months Ended September 30, 2023

Accumulated

Common Stock

Other

    

Number of

    

    

Retained

    

Comprehensive

    

    

Shares

    

Amount

    

Earnings

    

Loss

    

Total

Balance—June 30, 2023

 

16,755,772

$

9,835

$

735,957

$

(19,627)

$

726,165

Exercise of stock options

 

4,752

420

420

Vesting of RSUs

 

363,820

Shares issued under employee stock purchase plan

 

29,813

2,031

2,031

Stock-based compensation expense

 

7,089

7,089

Taxes paid related to net share settlement of equity awards

 

(166,315)

(19,358)

(2,881)

(22,239)

Net income

 

12,879

12,879

Other comprehensive loss

 

(1,888)

(1,888)

Balance—September 30, 2023

16,987,842

$

17

$

745,955

$

(21,515)

$

724,457

Three Months Ended September 30, 2024

Accumulated

Common Stock

Other

    

Number of

    

    

Retained

    

Comprehensive

    

    

Shares

    

Amount

    

Earnings

    

Loss

    

Total

Balance—June 30, 2024

17,055,497

$

24,289

$

861,230

$

(22,036)

$

863,483

Exercise of stock options

957

70

70

Vesting of RSUs

297,418

Shares issued under employee stock purchase plan

31,143

2,329

2,329

Stock-based compensation expense

6,422

6,422

Repurchase of common stock

(531,314)

(28,919)

(51,524)

(80,443)

Taxes paid related to net share settlement of equity awards

(142,952)

(4,174)

(17,089)

(21,263)

Net income

17,936

17,936

Other comprehensive loss

(2,039)

(2,039)

Balance—September 30, 2024

 

16,710,749

$

17

$

810,553

$

(24,075)

$

786,495

6

OSI SYSTEMS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)

(amounts in thousands)

Three Months Ended September 30, 

    

2023

    

2024

CASH FLOWS FROM OPERATING ACTIVITIES

    

Net income

$

12,879

$

17,936

Adjustments to reconcile net income to net cash provided by (used in) operating activities, net of effects from acquisitions:

Depreciation and amortization

 

9,568

11,450

Stock-based compensation expense

 

7,089

6,422

Recovery of losses on accounts receivable

(433)

(427)

Deferred income taxes

208

(851)

Amortization of debt discount and issuance costs

 

354

Other

 

42

(21)

Changes in operating assets and liabilities—net of business acquisitions:

Accounts receivable

 

55,868

(30,187)

Inventories

 

(82,035)

(54,458)

Prepaid expenses and other assets

 

(7,605)

(23,325)

Accounts payable

 

25,851

(4,952)

Accrued payroll and related expenses

(6,606)

(7,811)

Advances from customers

 

10,770

10,267

Deferred revenue

(7,142)

11,485

Other

 

(1,310)

26,958

Net cash provided by (used in) operating activities

 

17,144

(37,160)

CASH FLOWS FROM INVESTING ACTIVITIES

Acquisition of property and equipment

 

(5,239)

(7,705)

Proceeds from sale of property and equipment

44

85

Purchases of certificates of deposit

(2,068)

Proceeds from maturities of certificates of deposit

1,839

Acquisition of business, net of cash acquired

 

(75,500)

Payments for intangible and other assets

 

(4,154)

(4,372)

Net cash used in investing activities

 

(9,578)

(87,492)

CASH FLOWS FROM FINANCING ACTIVITIES

Net borrowings (repayments) on bank lines of credit

 

20,000

(125,000)

Proceeds from long-term debt

 

394

340,475

Payments on long-term debt

 

(2,073)

(2,078)

Proceeds from exercise of stock options and employee stock purchase plan

 

2,451

2,399

Payment of contingent consideration

(383)

(331)

Repurchase of common stock

 

(80,443)

Taxes paid related to net share settlement of equity awards

 

(22,239)

(21,263)

Net cash provided by (used in) financing activities

 

(1,850)

113,759

Effect of exchange rate changes on cash

 

125

593

Net increase (decrease) in cash and cash equivalents

 

5,841

(10,300)

Cash and cash equivalents—beginning of period

 

76,750

95,353

Cash and cash equivalents—end of period

$

82,591

$

85,053

Supplemental disclosure of cash flow information:

Cash paid, net during the period for:

Interest

$

5,455

$

5,231

Income taxes

$

6,795

$

13,540

See accompanying notes to condensed consolidated financial statements.

7

OSI SYSTEMS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. Basis of Presentation

The condensed consolidated financial statements include the accounts of OSI Systems, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation. The condensed consolidated financial statements have been prepared by management in accordance with accounting principles generally accepted in the United States of America (“GAAP”) and in conjunction with the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures required for annual financial statements have been condensed or excluded in accordance with SEC rules and regulations and GAAP applicable to interim unaudited financial statements. Accordingly, the condensed consolidated financial statements do not include all of the information and footnotes required by GAAP for audited annual financial statements. In the opinion of management, the condensed consolidated financial statements reflect all adjustments of a normal and recurring nature that are considered necessary for a fair presentation of the results for the interim periods presented. These unaudited condensed consolidated financial statements and the accompanying notes should be read in conjunction with the audited consolidated financial statements and accompanying notes included in our Annual Report on Form 10-K for the fiscal year ended June 30, 2024 filed with the SEC. The results of operations for the three months ended September 30, 2024 are not necessarily indicative of the operating results to be expected for the full 2025 fiscal year or any future periods.

Use of Estimates

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of sales, costs of sales and expenses during the reporting period. The most significant of these estimates and assumptions for our company relate to contract revenue, fair values of assets acquired and liabilities assumed in business combinations, values for inventories reported at lower of cost or net realizable value, stock-based compensation expense, income taxes, accrued warranty costs, contingent consideration, allowance for doubtful accounts, and the recoverability, useful lives and valuation of recorded amounts of long-lived assets, identifiable intangible assets and goodwill. Changes in estimates are reflected in the periods during which they become known. Due to the inherent uncertainty involved in making estimates, our actual amounts reported in future periods could differ materially from estimated amounts.

Earnings Per Share Computations

We compute basic earnings per share by dividing net income available to common stockholders by the weighted average number of common shares outstanding during the period. We compute diluted earnings per share by dividing net income available to common stockholders by the sum of the weighted average number of common shares and dilutive potential common shares outstanding during the period. Potential common shares consist of the shares issuable upon the exercise of stock options and restricted stock unit awards under the treasury stock method. The underlying equity component of the 2.25% convertible senior notes due 2029 (the “2029 Notes”) discussed in Note 8 to the condensed consolidated financial statements will have a net impact on diluted earnings per share when the average price of our common stock exceeds the conversion price of $191.98 because the principal amount of the 2029 Notes will be settled in cash upon conversion. There was no dilutive effect of the 2029 Notes for the three months ended September 30, 2024.

The following table sets forth the computation of basic and diluted earnings per share (in thousands, except per share amounts):

    

Three Months Ended September 30, 

2023

    

2024

Net income available to common stockholders

$

12,879

$

17,936

Weighted average shares outstanding—basic

 

16,825

16,742

Dilutive effect of equity awards

 

350

313

Weighted average shares outstanding—diluted

 

17,175

17,055

Basic earnings per share

$

0.77

$

1.07

Diluted earnings per share

$

0.75

$

1.05

Shares excluded from diluted earnings per share due to their anti-dilutive effect

8

22

8

Cash and Cash Equivalents

We consider all highly liquid investments with maturities of three months or less as of the acquisition date to be cash equivalents.

Our cash and cash equivalents totaled $85.1 million at September 30, 2024. Of this amount, approximately 81% was held by our foreign subsidiaries and subject to repatriation tax considerations. These foreign funds were held primarily by our subsidiaries in India, the United Kingdom, Singapore, Canada and Malaysia and to a lesser extent in Mexico, Egypt, Indonesia Albania and Australia, among other countries. We have cash holdings in financial institutions that exceed insured limits for such financial institutions; however, we mitigate this risk by utilizing international financial institutions which we believe to be of high credit quality.

Fair Value of Financial Instruments

Our financial instruments consist primarily of cash and cash equivalents, insurance company contracts, accounts receivable, accounts payable, debt instruments, an interest rate swap contract and foreign currency forward contracts. The carrying values of financial instruments, other than long-term debt instruments and our interest rate swap contract, are representative of their fair values due to their short-term maturities. The carrying values of our long-term debt instruments are considered to approximate their fair values because the interest rates of these instruments are variable or comparable to current rates for financing available to us. The fair values of our foreign currency forward contracts were not significant as of June 30, 2024 and September 30, 2024.

Fair value is the price that would be received in the sale of an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The “Level 1” category includes assets and liabilities at quoted prices in active markets for identical assets and liabilities. The “Level 2” category includes assets and liabilities from observable inputs other than quoted market prices. The “Level 3” category includes assets and liabilities for which valuation techniques are unobservable and significant to the fair value measurement. Our contingent payment obligations related to acquisitions, which are further discussed in Note 10 to the condensed consolidated financial statements, are in the “Level 3” category for valuation purposes.

The fair values of our financial assets and liabilities are categorized as follows (in thousands):

    

June 30, 2024

    

September 30, 2024

    

Level 1

    

Level 2

    

Level 3

    

Total

    

Level 1

    

Level 2

    

Level 3

    

Total

Assets—Insurance company contracts

$

$

49,679

$

$

49,679

$

$

52,430

$

$

52,430

Assets – Interest rate swap contract

$

$

4,735

$

$

4,735

$

$

676

$

$

676

Liabilities—Convertible debt

$

$

$

$

$

$

363,552

$

$

363,552

Liabilities—Contingent consideration

$

$

$

15,375

$

15,375

$

$

$

24,246

$

24,246

Derivative Instruments and Hedging Activity

Our use of derivatives consists of foreign currency forward contracts and an interest rate swap agreement. Our foreign currency forward contracts are utilized to partially mitigate certain balance sheet exposures or used as a net investment hedge to protect against potential changes resulting from short-term foreign currency fluctuations. These contracts have original maturities of up to three months. We also manage our risk to changes in interest rates using derivative instruments. We use fixed interest rate swaps to effectively convert a portion of the variable interest rate payments to fixed interest rate payments. We do not use hedging instruments for speculative purposes.

The net gains or losses from our foreign currency forward contracts, which are not designated as hedge instruments, are reported in the consolidated statements of operations, and the amounts reported for the three months ended September 30, 2023 and 2024 were not significant. The fair value of our foreign currency forward contracts is estimated using a standard valuation model and market-based observable inputs over the contractual term. Unrealized gains are recognized as assets and unrealized losses are recognized as liabilities. As of June 30, 2024 and September 30, 2024, we held foreign currency forward contracts with notional amounts totaling $96.4 million and $101.7 million, respectively. Unrealized gains and losses from our foreign currency forward contracts as of June 30, 2024 and September 30, 2024 were not significant.

9

Our interest rate swap agreement was entered into to improve the predictability of cash flows from interest payments related to our variable, Secured Overnight Financing Rate (“SOFR”) based debt. The interest rate swap matures in December 2026. The interest rate swap is considered an effective cash flow hedge, and as a result, the net gains or losses on such instrument are reported as a component of other comprehensive income (loss) in our consolidated financial statements and are reclassified as net income when the underlying hedged interest impacts earnings. A qualitative and quantitative assessment of the interest rate swap hedge effectiveness is performed on a quarterly basis, unless facts and circumstances indicate that the hedge may no longer be highly effective.

As of June 30, 2024 and September 30, 2024, the notional amount of the derivative instruments designated as an interest rate swap hedge was $175 million. The fair value of the interest rate swap contract as of as of June 30, 2024 and September 30, 2024 is recorded in Other assets within the consolidated balance sheet.

The effect of the cash flow hedges on other comprehensive income (loss) and earnings for the periods presented was as follows:

    

Three Months Ended September 30, 

2023

    

2024

Total interest and other expense, net presented in the condensed consolidated statements of operations in which the effects of cash flow hedges are recorded

$

(5,748)

$

(7,359)

Gain (loss) recognized in other comprehensive income (loss), net of tax

1,147

(3,220)

Amount reclassified from accumulated other comprehensive income (loss) to interest expense, net

872

900

Recent Accounting Pronouncements

From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (“FASB”) and other regulatory bodies that are adopted as of the specified effective dates. Unless otherwise discussed, management believes that the impact of recently issued standards, which are not yet effective, will not have a material impact on our Consolidated Financial Statements upon adoption. There were no new pronouncements adopted in the first quarter of fiscal year 2025.

In November 2023, the FASB issued Accounting Standards Update 2023-07, “Improvements to Reportable Segment Disclosures” (“ASU 2023-07”), which requires disclosures of significant expenses by segment and interim disclosure of items that were previously required on an annual basis. ASU 2023-07 is to be applied on a retrospective basis and is effective for fiscal years beginning after December 15, 2023 and interim periods within fiscal years beginning after December 15, 2024 with early adoption permitted. We are evaluating the potential impact of ASU 2023-07 on disclosures in our Consolidated Financial Statements.

In December 2023, the FASB issued Accounting Standards Update 2023-09, “Improvements to Income Tax Disclosures” (“ASU 2023-09”), which provides for additional disclosures primarily related to the income tax rate reconciliations and income taxes paid. ASU 2023-09 requires entities to annually disclose the income tax rate reconciliation using both amounts and percentages, considering several categories of reconciling items, including state and local income taxes, foreign tax effects, tax credits and nontaxable or nondeductible items, among others. Disclosure of the reconciling items is subject to a quantitative threshold and disaggregation by nature and jurisdiction. ASU 2023-09 also requires entities to disclose net income taxes paid to or received from federal, state and foreign jurisdictions, as well as by individual jurisdiction, subject to a five percent quantitative threshold. ASU 2023-09 may be adopted on a prospective or retrospective basis and is effective for fiscal years beginning after December 15, 2024 with early adoption permitted. We are evaluating the potential impact of ASU 2023-09 on disclosures in our Consolidated Financial Statements.

10

2. Business Combinations

Under Accounting Standards Codification Topic 805, Business Combinations (“ASC 805”), the acquisition method of accounting requires us to record assets acquired less liabilities assumed from an acquisition at their estimated fair values at the date of acquisition. Any excess of the total estimated purchase price over the estimated fair value of the net assets acquired should be recorded as goodwill. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired customers, acquired technology, trade names, useful lives and discount rates. Management’s estimates of fair value are based upon assumptions which are believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. During the measurement period for fair value, which is up to one year from the acquisition date, as additional information that existed at the acquisition date becomes available, we may record adjustments to the preliminary assets acquired and liabilities assumed. Upon the conclusion of the measurement period, any subsequent adjustments are included in earnings.

Fiscal Year 2025 Business Acquisition

In September 2024, we (through our Security division) acquired 100% of the shares of common stock of a privately held provider of critical military, space and surveillance solutions for approximately $76.0 million, plus up to $24.0 million in potential contingent consideration. We paid $75.5 million in cash at the closing of the transaction and recorded a holdback liability of $0.5 million which is expected to be paid before the end of the current fiscal year. The cash paid for this acquisition was financed with borrowings from our credit facility. The acquisition date fair value of the contingent consideration was $9.7 million, therefore, when combined with the amount of cash paid at close and the holdback amount, total purchase consideration was $85.7 million which has been allocated to the preliminary fair value of assets acquired and liabilities assumed. The preliminary acquisition date fair value of total assets acquired was $115.0 million which comprised accounts receivable of $29.8 million, inventory and other current assets of $5.9 million, property and equipment of $7.0 million, goodwill of $28.4 million and other intangible assets of $43.9 million. The goodwill recognized for this business acquisition is not deductible for income tax purposes. Other intangible assets include amortizable intangible assets of $35.9 million with amortization periods of 7 to 10 years and an indefinite-lived intangible asset of $8.0 million. The preliminary acquisition date fair value of total liabilities assumed was $29.3 million, which includes a deferred tax liability of $8.4 million that was recognized primarily due to the acquisition of other intangible assets. The preliminary valuation of the assets acquired, liabilities assumed and contingent consideration in the acquisition is subject to revision. If additional information becomes available, we may further revise the preliminary purchase price allocation as soon as practical, but no later than one year from the acquisition date. Revenue from this acquired business was $4.0 million from the acquisition date through September 30, 2024.

Fiscal Year 2024 Business Acquisition

In December 2023, we (through our Optoelectronics and Manufacturing division) acquired a privately held contract manufacturer for approximately $6.3 million. The acquisition was financed with cash on hand. The goodwill recognized for this business acquisition is deductible for income tax purposes.

In October 2023, we (through our Security division) acquired a privately held provider of radiation detection technology for approximately $2.8 million, plus up to $3.6 million in potential contingent consideration. The acquisition was financed with cash on hand. The goodwill recognized for this business acquisition is not deductible for income tax purposes.

11

3. Balance Sheet Details

The following tables set forth details of selected balance sheet accounts (in thousands):

June 30, 

September 30, 

Accounts receivable, net

    

2024

    

2024

Accounts receivable

$

667,227

$

706,844

Less allowance for doubtful accounts

 

(19,072)

(19,234)

Total

$

648,155

$

687,610

June 30, 

September 30, 

Inventories

    

2024

    

2024

Raw materials

$

238,086

$

242,738

Work-in-process

 

66,910

86,425

Finished goods

 

92,943

126,867

Total

$

397,939

$

456,030

June 30, 

September 30, 

Property and equipment, net

    

2024

    

2024

Land

$

15,494

$

16,125

Buildings, civil works and improvements

 

48,552

53,166

Leasehold improvements

 

13,573

15,462

Equipment and tooling

 

146,819

150,072

Furniture and fixtures

 

3,348

3,409

Computer equipment

 

22,597

23,870

Computer software

 

29,195

29,710

Computer software implementation in process

6,514

6,015

Construction in process

 

6,986

10,153

Total

 

293,078

307,982

Less accumulated depreciation and amortization

 

(179,111)

(183,369)

Property and equipment, net

$

113,967

$

124,613

Depreciation and amortization expense for property and equipment was $4.9 million and $6.7 million , respectively, for the three months ended September 30, 2023 and 2024.

4. Goodwill and Intangible Assets

The changes in the carrying value of goodwill by segment for the three-month period ended September 30, 2024 were as follows (in thousands):

Optoelectronics

and

Security

Manufacturing

Healthcare

    

Division

    

Division

    

Division

    

Consolidated

Balance as of June 30, 2024

$

232,215

$

70,807

$

48,458

$

351,480

Goodwill acquired during the period (see Note 2)

 

28,372

28,372

Foreign currency translation adjustment

 

223

1,201

168

1,592

Balance as of September 30, 2024

$

260,810

$

72,008

$

48,626

$

381,444

12

Intangible assets consisted of the following (in thousands):

June 30, 2024

September 30, 2024

Gross

Gross

Carrying

Accumulated

Intangibles

Carrying

Accumulated

Intangibles

    

Value

    

Amortization

    

Net

    

Value

    

Amortization

    

Net

Amortizable assets:

Software development costs

$

79,228

$

(10,646)

$

68,582

$

83,339

$

(11,353)

$

71,986

Patents

9,116

(3,861)

5,255

9,265

(3,975)

5,290

Developed technology

70,186

(45,740)

24,446

97,284

(47,801)

49,483

Customer relationships

51,113

(41,421)

9,692

42,901

(26,051)

16,850

Total amortizable assets

 

209,643

(101,668)

107,975

232,789

(89,180)

143,609

Non-amortizable assets:

Trademarks

 

31,554

31,554

39,613

39,613

Total intangible assets

$

241,197

$

(101,668)

$

139,529

$

272,402

$

(89,180)

$

183,222

During the three months ended September 30, 2024 intangible assets of $43.9 million were included in the business acquisition described in Note 2.

Amortization expense related to intangible assets was $4.7 and $4.8 million for the three months ended September 30, 2023 and 2024, respectively.

At September 30, 2024, the estimated future amortization expense for amortizable intangible assets was as follows (in thousands):

Fiscal Year

2025 (remaining 9 months)

    

$

15,814

2026

 

17,965

2027

 

16,356

2028

 

15,532

2029

13,533

Thereafter

 

64,409

Total

$

143,609

Software development costs for software products incurred before establishing technological feasibility are charged to operations. Software development costs incurred after establishing technological feasibility are capitalized on a product-by-product basis until the product is available for general release to customers at which time amortization begins. Annual amortization, charged to cost of goods sold, is the amount computed using the ratio that current revenues for a product bear to the total current and anticipated future revenues for that product. In the event that future revenues are not estimable, such costs are amortized on a straight-line basis over the remaining estimated economic life of the product. Amortizable assets that have not yet begun to be amortized are included in Thereafter in the table above. For the three months ended September 30, 2023 and 2024, we capitalized software development costs in the amounts of $4.0 million and $4.2 million, respectively.

5. Contract Assets and Liabilities

We enter into contracts to sell products and provide services, and we recognize contract assets and liabilities that arise from these transactions. We recognize revenue and corresponding accounts receivable according to ASC Topic 606, Revenue from Contracts with Customers (“ASC 606”). When we recognize revenue in advance of the point in time at which contracts give us the right to invoice a customer, we record this as unbilled revenue, which is included in accounts receivable, net, on the consolidated balance sheets. We may also receive consideration, per the terms of a contract, from customers prior to transferring control of goods to the customer. We record customer deposits as contract liabilities. Additionally, we may receive payments, most typically under service and warranty contracts, at the onset of the contract and before services have been performed. In such instances, we record a deferred revenue liability in either Other accrued expenses and current liabilities or Other long-term liabilities. We recognize these contract liabilities as sales after all revenue recognition criteria are met.

13

The table below shows the balance of contract assets and liabilities as of June 30, 2024 and September 30, 2024, including the change between the periods. There were no substantial non-current contract assets for the periods presented.

Contract Assets (in thousands)

    

June 30, 

    

September 30, 

    

    

 

    

2024

    

2024

    

Change

    

% Change

 

Unbilled revenue (included in accounts receivable, net)

$

338,944

$

346,589

$

7,645

2

%

Contract Liabilities (in thousands)

    

June 30, 

    

September 30, 

    

    

 

    

2024

    

2024

    

Change

    

% Change

Advances from customers

$

53,431

$

63,996

$

10,565

20

%

Deferred revenue—current

 

46,855

56,880

10,025

21

%

Deferred revenue—long-term

 

22,809

23,750

941

4

%

Contract Assets. Contract assets increased by approximately $7.6 million due to $27.9 million from the business acquisition described in Note 2, partially offset by decreases in unbilled revenue primarily from the achievement of certain milestones in our Security division which gives us the right to invoice customers.

Remaining Performance Obligations. Remaining performance obligations related to ASC 606 represent the portion of the transaction price allocated to performance obligations under an original contract with a term greater than one year which are fully or partially unsatisfied at the end of the period. As of September 30, 2024, the portion of the transaction price allocated to remaining performance obligations was approximately $805.2 million. We expect to recognize revenue on approximately of the remaining performance obligations over the next 12 months, and the remainder is expected to be recognized thereafter. During the three months ended September 30, 2024, we recognized revenue of $32.5 million from contract liabilities existing at the beginning of the period.

Practical Expedients. In cases where we are responsible for shipping after the customer has obtained control of the goods, we have elected to treat the shipping activities as fulfillment activities rather than as separate performance obligations. Additionally, we have elected to capitalize the cost to obtain a contract only if the period of amortization would be longer than one year. We only give consideration to whether a customer agreement has a financing component if the period of time between transfer of goods and services and customer payment is greater than one year.

6. Leases

The components of operating lease expense were as follows (in thousands):

Three Months Ended September 30, 

    

2023

    

2024

Operating lease cost

$

2,805

$

2,813

Variable lease cost

265

194

Short-term lease cost

325

497

$

3,395

$

3,504

14

Supplemental disclosures related to operating leases were as follows (in thousands):

    

Balance Sheet Category

    

June 30, 2024

    

September 30, 2024

Operating lease right of use (“ROU”) assets, net

 

Other assets

$

30,040

$

28,994

Operating lease liabilities, current portion

 

Other accrued expenses and current liabilities

$

9,706

$

9,745

Operating lease liabilities, long-term

 

Other long-term liabilities

21,127

20,042

Total operating lease liabilities

$

30,833

$

29,787

Weighted average remaining lease term

3.6 years

Weighted average discount rate

4.6

%

Supplemental cash flow information related to operating leases was as follows (in thousands):

    

Three Months Ended September 30, 

    

2023

    

2024

Cash paid for operating lease liabilities

$

2,994

$

2,895

ROU assets obtained in exchange for new lease obligations

 

1,791

252

Maturities of operating lease liabilities at September 30, 2024 were as follows (in thousands):

    

September 30, 2024

Less than one year

$

10,840

1 – 2 years

 

9,407

2 – 3 years

 

6,821

3 – 4 years

 

2,533

4 – 5 years

 

1,272

Thereafter

 

1,432

 

32,305

Less: imputed interest

 

(2,518)

Total lease liabilities

$

29,787

7. Restructuring and Other Charges

We endeavor to align our global capacity and infrastructure with demand by our customers and to effectively integrate acquisitions and thereby improve our operational efficiency.

During the three months ended September 30, 2024, we recognized $1.2 million in restructuring and other charges, which included $0.6 million for employee terminations, $0.2 million for facility closure costs for operational efficiency activities, and $0.4 million in acquisition related costs.

During the three months ended September 30, 2023, we recognized $0.5 million in restructuring and other charges, which included $0.1 million in legal charges, $0.1 million for employee terminations, $0.1 million for facility closure costs for operational efficiency activities, and $0.2 million in acquisition related costs.

15

The following tables summarize restructuring and other charges for the periods set forth below (in thousands):

Three Months Ended September 30, 2023

    

    

Optoelectronics and

    

    

    

Manufacturing

Healthcare

    

Security Division

    

Division

    

Division

    

Corporate

    

Total

Acquisition-related costs

$

208

$

$

$

$

208

Employee termination costs

13